P25789 (PSA4_HUMAN) Homo sapiens (Human)

Proteasome subunit alpha type-4 UniProtKBInterProSTRINGInteractive Modelling

261 aa; Sequence (Fasta) ; (Isoform 2; ) 35 identical sequences

Sequence Features

 5-27Proteasome alpha-subunit, N-terminal domain
IPR000426PF10584
 30-215Proteasome, subunit alpha/beta
IPR001353PF00227

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
The human 26S Proteasome at 6.8 Ang. Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
5ln31-261
Human Constitutive 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4r3o2-251
Crystal Structure of the mammalian 20S proteasome at 2.75 A resolution Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
30×MG;1iru2-251
Human constitutive 20S proteasome in complex with carfilzomib Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
3BV;4r672-251
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
5vfo2-251
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;5vfp2-251
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;5vfq2-251
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;5vfr2-251
'Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;5vfs2-251
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;5vft2-251
'Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S P... Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;5vfu2-251
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6msb2-251
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6msd2-251
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6mse2-251
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;5t0g2-251
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
MG;ZN;ATP;ADP;6msg2-251
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;5t0h2-251
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;ATP;6msh2-251
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;5t0i2-251
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;5t0j2-251
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6msj2-251
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;MG;ATP;6msk2-251
The human 26S proteasome at 3.9 A Heteromer
O14818; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436;
MG;ADP;ATP;5l4g2-251
Structure of the human 26S proteasome bound to USP14-UbAl Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ADP;5gjq2-251
Human Immunoproteasome 20S particle in complex with compound 1 Heteromer
O14818; P20618; P25786; P25787; P25788; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
12×NA;SCN;HUJ;6e5b2-250
Native human 20S proteasome at 1.8 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE; 10×MG; 57×CL;5le52-249
Human 20S proteasome complex with Oprozomib at 1.9 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE; 10×MG; 58×CL;5ley2-249
Human 20S proteasome complex with Delanzomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6V7;K;1PE; 10×MG; 52×CL;5lf42-249
Human 20S proteasome complex with Ixazomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6V8;K;1PE; 10×MG; 51×CL;5lf72-249
Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE;6VC; 10×MG; 56×CL;5lf12-249
Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
PHQ;K;1PE; 10×MG; 55×CL;5lf62-249
Human 20S proteasome complex with Bortezomib at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE; 10×MG;BO2; 51×CL;5lf32-249
Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;ACT; 10×MG;1PE;5lez2-249
Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;MG;1PE;5lex2-249
Human 20S proteasome complex with Epoxomicin at 2.4 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;1PE; 10×MG; 58×CL;5lf02-249
Endogeneous native human 20S proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6r702-249
Human 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6rgq2-248
Human 26S proteasome in complex with Oprozomib Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6;
ADP;5m322-245
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
KNM;5a0q2-244
'Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selective... Heteromer
O14818; P20618; P25786; P25787; P25788; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
BZ7;6avo2-241
Human 20S-PA200 Proteasome Complex Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
I6P;K0W;6rey30-246

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomer-1.845t0j.1.D1-180
100.00